Tomàs Pinós

1.2k total citations
58 papers, 810 citations indexed

About

Tomàs Pinós is a scholar working on Rheumatology, Molecular Biology and Genetics. According to data from OpenAlex, Tomàs Pinós has authored 58 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Rheumatology, 25 papers in Molecular Biology and 20 papers in Genetics. Recurrent topics in Tomàs Pinós's work include Glycogen Storage Diseases and Myoclonus (34 papers), Genetic Neurodegenerative Diseases (12 papers) and Genetics and Neurodevelopmental Disorders (11 papers). Tomàs Pinós is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (34 papers), Genetic Neurodegenerative Diseases (12 papers) and Genetics and Neurodevelopmental Disorders (11 papers). Tomàs Pinós collaborates with scholars based in Spain, Denmark and United States. Tomàs Pinós's co-authors include Antoni L. Andreu, Alejandro Lucía, Gisela Nogales‐Gadea, Astrid Brull, Miguel A. Martı́n, Joaquı́n Arenas, Noemí de Luna, Alfredo Santalla, Francina Munell and Ramón Martí and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tomàs Pinós

57 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomàs Pinós Spain 17 348 347 232 175 139 58 810
Gunter Scharer United States 17 217 0.6× 616 1.8× 232 1.0× 108 0.6× 46 0.3× 29 1.1k
Bernd Dworniczak Germany 17 127 0.4× 535 1.5× 230 1.0× 74 0.4× 73 0.5× 41 1.2k
Amal Alhashem Saudi Arabia 19 67 0.2× 616 1.8× 447 1.9× 62 0.4× 109 0.8× 76 1.1k
David Kronn United States 15 274 0.8× 362 1.0× 270 1.2× 195 1.1× 284 2.0× 35 1.0k
Claudio Bruno Italy 20 246 0.7× 833 2.4× 203 0.9× 191 1.1× 66 0.5× 30 1.3k
Stefen Brady United Kingdom 15 316 0.9× 356 1.0× 42 0.2× 50 0.3× 132 0.9× 38 836
Gözde Yeşil Türkiye 15 67 0.2× 290 0.8× 205 0.9× 54 0.3× 67 0.5× 78 679
Carl Fratter United Kingdom 26 72 0.2× 945 2.7× 184 0.8× 158 0.9× 151 1.1× 47 1.3k
Elżbieta Ciara Poland 17 95 0.3× 647 1.9× 278 1.2× 103 0.6× 37 0.3× 88 1.1k
Mohamed S. Abdel‐Hamid Egypt 15 74 0.2× 495 1.4× 257 1.1× 100 0.6× 29 0.2× 97 898

Countries citing papers authored by Tomàs Pinós

Since Specialization
Citations

This map shows the geographic impact of Tomàs Pinós's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomàs Pinós with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomàs Pinós more than expected).

Fields of papers citing papers by Tomàs Pinós

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomàs Pinós. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomàs Pinós. The network helps show where Tomàs Pinós may publish in the future.

Co-authorship network of co-authors of Tomàs Pinós

This figure shows the co-authorship network connecting the top 25 collaborators of Tomàs Pinós. A scholar is included among the top collaborators of Tomàs Pinós based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomàs Pinós. Tomàs Pinós is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boraíta, Araceli, Gonzalo Saco‐Ledo, Lidia B. Alejo, et al.. (2025). Physical exercise intervention in glycogen storage disease IIIa: Feasibility and multisystem benefits. Experimental Physiology. 111(1). 153–166.
2.
Plaza‐Florido, Abel, et al.. (2024). Can exercise kill tumors?. Journal of sport and health science. 14. 101001–101001. 1 indexed citations
3.
Valenzuela, Pedro L., Alfredo Santalla, Lidia B. Alejo, et al.. (2024). Acute ketone supplementation in the absence of muscle glycogen utilization: Insights from McArdle disease. Clinical Nutrition. 43(3). 692–700. 4 indexed citations
4.
Maas, Daphne, Edith H. C. Cup, Jan T. Groothuis, et al.. (2023). Toward an Understanding of GSD5 (McArdle disease): How Do Individuals Learn to Live with the Metabolic Defect in Daily Life. Journal of Neuromuscular Diseases. 11(1). 103–116. 2 indexed citations
5.
Valenzuela, Pedro L., Alfredo Santalla, Lidia B. Alejo, et al.. (2023). Dose–response effect of pre-exercise carbohydrates under muscle glycogen unavailability: Insights from McArdle disease. Journal of sport and health science. 13(3). 398–408. 4 indexed citations
6.
García‐Consuegra, Inés, Tomàs Pinós, Cristina Domínguez‐González, et al.. (2022). Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis. International Journal of Molecular Sciences. 23(9). 4650–4650. 1 indexed citations
7.
Santalla, Alfredo, Gisela Nogales‐Gadea, Pedro L. Valenzuela, et al.. (2022). Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?. Molecular Metabolism. 66. 101648–101648. 8 indexed citations
8.
Brull, Astrid, Gisela Nogales‐Gadea, Antoni L. Andreu, et al.. (2021). Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies. Genes. 13(1). 74–74. 5 indexed citations
9.
Salazar-Martı́nez, Eduardo, Alfredo Santalla, Pedro L. Valenzuela, et al.. (2021). The Second Wind in McArdle Patients: Fitness Matters. Frontiers in Physiology. 12. 744632–744632. 10 indexed citations
10.
Luna, Noemí de, Gisela Nogales‐Gadea, Antoni L. Andreu, et al.. (2020). Preclinical Research in Glycogen Storage Diseases: A Comprehensive Review of Current Animal Models. International Journal of Molecular Sciences. 21(24). 9621–9621. 16 indexed citations
11.
Luna, Noemí de, Astrid Brull, Miguel A. Martı́n, et al.. (2019). Absence of p.R50X Pygm read-through in McArdle disease cellular models. Disease Models & Mechanisms. 13(1). 10 indexed citations
12.
Brull, Astrid, Alejandro Lucía, Miguel A. Martı́n, et al.. (2019). Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model. Scientific Reports. 9(1). 5116–5116. 12 indexed citations
13.
Fiuza‐Luces, Carmen, Alejandro Santos‐Lozano, Francisco Llavero, et al.. (2018). Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics‐based analysis in the McArdle mouse model. The Journal of Physiology. 596(6). 1035–1061. 21 indexed citations
14.
García‐Consuegra, Inés, Rosario Francisco‐Velilla, Tomàs Pinós, et al.. (2018). Missense mutations have unexpected consequences: The McArdle disease paradigm. Human Mutation. 39(10). 1338–1343. 12 indexed citations
15.
Pinós, Tomàs, et al.. (2017). Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse. Molecular Genetics and Metabolism. 123(1). 21–27. 8 indexed citations
16.
Scarpelli, Mauro, Noemí de Luna, Alessandra Ariatti, et al.. (2017). Identification and characterization of the novel m.8305C>T MTTK and m.4440G>A MTTM gene mutations causing mitochondrial myopathies. Neuromuscular Disorders. 28(2). 137–143. 4 indexed citations
17.
García‐Consuegra, Inés, Alberto Blázquez, Carlos Rubio-Terrés, et al.. (2016). Taking advantage of an old concept, “illegitimate transcription”, for a proposed novel method of genetic diagnosis of McArdle disease. Genetics in Medicine. 18(11). 1128–1135. 8 indexed citations
18.
Krag, Thomas, et al.. (2016). Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease. Journal of Neuropathology & Experimental Neurology. 75(5). 441–454. 25 indexed citations
19.
Blanco‐Grau, Albert, J Coll, M Melia, et al.. (2013). Identification and biochemical characterization of the novel mutation m.8839G>C in the mitochondrial ATP6 gene associated with NARP syndrome. Genes Brain & Behavior. 12(8). 812–820. 21 indexed citations
20.
Pacheu‐Grau, David, Aurora Gómez-Durán, Ester López‐Gallardo, et al.. (2011). ‘Progress’ renders detrimental an ancient mitochondrial DNA genetic variant. Human Molecular Genetics. 20(21). 4224–4231. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gunter Scharer Breakdown of academic impact, for papers by Bernd Dworniczak Breakdown of academic impact, for papers by Amal Alhashem Breakdown of academic impact, for papers by David Kronn Breakdown of academic impact, for papers by Claudio Bruno Breakdown of academic impact, for papers by Stefen Brady Breakdown of academic impact, for papers by Gözde Yeşil Breakdown of academic impact, for papers by Carl Fratter Breakdown of academic impact, for papers by Elżbieta Ciara Breakdown of academic impact, for papers by Mohamed S. Abdel‐Hamid
Rankless by CCL
2026